iShares Trust - iShares Biotechnology ETF Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 13.1yrs |
| Board average tenure | 20.1yrs |
Recent management updates
No updates
Recent updates
iShares Biotechnology ETF: Playing Defense
Dec 10IBB: A Near-20x P/E Is Historically Pricey, Technical Trends Neutral
Oct 14iShares Biotechnology ETF: Significant Upside Potential As Sector Gains Momentum
Jul 28Biotech Stocks 2024 Second Half Outlook - Buy Biotechs
Jul 09IBB: Let It Rest
Mar 26IBB ETF: On Sale And Rich Option Premium To Boot
Sep 20IBB: Biotechnology Offers A Compelling Opportunity As It Builds Up Momentum
Jul 19IBB: M&As Are Back
Jun 21XBI Or IBB: How To Play The Oversold Biotech Most Efficiently
Jun 09IBB: Lows After Highs Highlight Failing Growth Narratives And Overvaluation In Biotech Sector
May 09IBB: Healthcare Dashboard For April
Apr 18XBI And IBB: You May Keep Laughing While We Keep Buying This March 2020-Like Opportunity
Jan 28Biotech Investing: Large Trading Volumes Suggest Better Days Are Ahead
Jan 17IBB And XBI: 4 Reasons To Buy Biotech Stocks Ahead Of 2022
Dec 06IBB: Healthcare Dashboard For October
Oct 15IBB: Risks And Hedging
Sep 21IBB: Growth And Innovation
Jun 28AbbVie rated buy at Mizuho despite patent cliff for Humira
Jan 11NASDAQ Biotech Index cross 5,000-mark as vaccine makers and gene-editors surge
Jan 08iShares Nasdaq Biotechnology ETF: Continuous Innovation For Mankind
Jan 06Citing uncertainty, Baird stays neutral on Biotech for 2021
Jan 04COVID-19 vaccine makers: Looking back on 2020 seeking insights for 2021
Dec 31CEO
iShares Trust - iShares Biotechnology ETF has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Portfolio Manager | no data | no data | no data | |
| Portfolio Manager | no data | no data | no data | |
| Portfolio Manager | no data | no data | no data |
13.1yrs
Average Tenure
Experienced Management: IBB's management team is seasoned and experienced (13.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interested Trustee | 16.1yrs | no data | no data | |
| Lead Trustee | 25.1yrs | US$115.00k | no data | |
| Independent Chairman | 18.1yrs | US$90.00k | no data | |
| Interested Trustee | 22.1yrs | US$90.00k | no data | |
| Independent Trustee | 20.1yrs | US$90.00k | no data | |
| Independent Trustee | 20.1yrs | US$110.00k | no data | |
| Independent Trustee | 20.1yrs | US$90.00k | no data | |
| Trustee | 12.1yrs | no data | no data | |
| Independent Trustee | 14.1yrs | no data | no data |
20.1yrs
Average Tenure
69yo
Average Age
Experienced Board: IBB's board of directors are seasoned and experienced ( 20.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/02 02:45 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2023/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
iShares Trust - iShares Biotechnology ETF is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|